Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - 9 months ended Sep. 30, 2017 - USD ($)
Total
Common Stock [Member]
Additional Paid In Capital [Member]
Stockholders Note Receivable [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Balance at Dec. 31, 2016 $ (329,421) $ 101,309 $ 78,106,645 $ (58,824) $ 120,187 $ (78,598,738) $ 0
Balance (in shares) at Dec. 31, 2016   10,130,883         0
Stock-Based Compensation 700,833   700,833        
Cancellation of Stockholder Note Receivable 58,824     58,824      
Issuance of Common Stock in Offerings, Net of Offering Costs of $1,086,736 8,611,683 $ 59,788 8,551,895        
Issuance of Common Stock in Offerings, Net of Offering Costs of $1,086,736 (in shares)   5,978,817          
Issuance of Series B Preferred Stock, Net of Offering Costs of $246,333 1,977,500   1,977,480       $ 20
Issuance of Series B Preferred Stock, Net of Offering Costs of $246,333 (in shares)             1,995
Conversion of Series B Preferred Stock 0 $ 9,300 (9,286)       $ (14)
Conversion of Series B Preferred Stock (in shares)   930,000         (1,395)
Exercise of Common Stock Options 40,718 $ 611 40,107        
Exercise of Common Stock Options (in shares)   61,078          
Issuance of Restricted Stock 0 $ 1,040 (1,040)        
Issuance of Restricted Stock (in shares)   104,000          
Foreign Currency Translation Adjustment 6,193       6,193    
Net Loss (10,386,885)         (10,386,885)  
Balance at Sep. 30, 2017 $ 679,445 $ 172,048 $ 89,366,634 $ 0 $ 126,380 $ (88,985,623) $ 6
Balance (in shares) at Sep. 30, 2017   17,204,778         600